Target intelligence / Profile preview

Colonic microbiota fermentation

Molecular classification: Other (Physiological process), Microbial metabolism

Overview

Colonic microbiota fermentation refers to the anaerobic microbial breakdown of non-digestible dietary fibers, proteins, and other substrates in the colon, resulting in the formation of numerous metabolites, chiefly short-chain fatty acids (such as acetate, propionate, and butyrate), vitamins, and gases. This process is essential for host health, supporting the energy needs of colonic epithelial cells, regulating immune function, and helping protect against pathogens. However, dysregulation or imbalance in fermentation products can contribute to diseases such as inflammatory bowel disease, colon cancer, and metabolic disorders.

Other names: Colonic fermentationGut microbiota fermentationIntestinal microbial fermentation

Mechanism of action

Not applicable for any single agent; however, dietary interventions (e.g., prebiotics, probiotics, fiber supplements) alter this process by modulating microbiota composition and fermentation output

Biological functions

Metabolism of undigestible carbohydrates and proteinsProduction of short-chain fatty acids (acetate, propionate, butyrate)Generation of gases (CO₂, H₂, methane, etc.)Vitamin biosynthesis (B vitamins, vitamin K)Maintenance of intestinal homeostasisModulation of immune response

Disease associations

Inflammation (e.g., inflammatory bowel disease)Cancer (role in colon cancer risk from different metabolites)Infection (modulation of pathogen colonization)Other (irritable bowel syndrome, metabolic diseases)

Safety considerations

Excess fermentation can lead to bloating, gas, and discomfort (as in irritable bowel syndrome)Production of potentially toxic metabolites (e.g., phenols, indoles, amines, hydrogen sulfide) from protein fermentation in excess

Interacting drugs

Not applicable as direct drugs, though the microbiota may metabolize drugs, affecting their activity

Biomarkers

Short-chain fatty acid (SCFA) levels (e.g., butyrate, acetate, propionate)Fecal microbiota compositionGaseous metabolites (e.g., breath H₂ tests)

Beyond the preview

Go deeper on Colonic microbiota fermentation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colonic microbiota fermentation.

Explore the full profile